UCTT
Get informed when a big investor buys or sells
+ FollowOvervalued by 101.2% based on the discounted cash flow analysis.
| Market cap | $5.44 Billion |
|---|---|
| Enterprise Value | $5.89 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4 |
| Beta | 1.95 |
| Outstanding Shares | 45,300,000 |
| P/E Ratio | -28.3 |
|---|---|
| PEG | -10.97 |
| Price to Sales | 2.74 |
| Price to Book Ratio | 8.21 |
| Enterprise Value to Revenue | 2.85 |
| Enterprise Value to EBIT | -53.82 |
| Enterprise Value to Net Income | -31 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 1.24 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0477▼ 182.76% |
|---|---|
| Total Calls | 4,915,300▲ 11045.80% |
| Total Puts | 234,500▲ 183.56% |
Holdings and activity of institutional investors.
| Ownership % | 99.39%▲ 5.80% |
|---|---|
| Total Invested | $2.80B▲ 159.56% |
| Investors Holding | 344▲ 101.00% |
No data
Controls corporate tax rates, R&D tax credits, and tariffs on Chinese imports, all of which are primary drivers of UCTT's valuation and cost structure.
Determines the actual funding levels for the CHIPS Act and other federal industrial grants that directly benefit the semiconductor ecosystem.
This committee has jurisdiction over the CHIPS and Science Act, which provides massive subsidies and R&D support for the semiconductor industry, including equipment and subsystems.
Semiconductor manufacturing is at the center of US-China trade tensions; this committee influences export controls and diplomatic relations with Taiwan, where many of UCTT's customers reside.